Loading...
| A04011 | Pages: NA | Dec 2021 | 5328 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Blood Collection Market
Request Now !Blood is collected as whole blood (WB) by blood donation processes, and later it can be separated into various components by a process called as apheresis. The amount of blood drawn varies and should not be more than 1% of the body weight of the donor. The collection can be done with help of an automated equipment that collects only specific components of blood or blood can also be collected manually.
The growth of the blood collection market is driven by rise in incidence of trauma and accidents, and surge in number of surgical procedures carried out worldwide. In addition, growth in awareness increase in government initiatives about blood donation and are expected to boost the demand for blood collection products. However, risks related to blood transfusion in underdeveloped countries impede this growth.
The global blood collection market is segmented based on product, application, end user, and region. Based on product, it is classified into blood collection needles and syringes, blood collection tubes, blood lancets, blood bags, vials, and others. Blood collection tubes are further categorized into EDTA, heparin, serum-separating tubes, and plasma-separating tubes. Based on application, the market is divided into diagnostics and treatment. Diagnostics application is further bifurcated into infectious diseases and non-infectious diseases. By end user, the market is categorized into hospitals & diagnostic centers, blood banks, and others.
Based on region, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed at the country level to determine the market size and forecast for each segment and sub-segment.
Comprehensive competitive analysis and profiles of major players, such as Abbott Laboratories Inc., Medtronic, Becton Dickinson and Company, Terumo Corporation, Nipro Medical Corporation, Qiagen, F.L. Medical SRL, Greiner Holding AG, Haemonetics Corporation, and Sarstedt AG & Co., are provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL BLOOD COLLECTION MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. BLOOD COLLECTION NEEDLES AND SYRINGES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. BLOOD COLLECTION TUBES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. EDTA
4.3.5. Heparin
4.3.6. Serum-separating Tubes
4.3.7. Plasma-separating Tubes
4.4. BLOOD LANCETS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. BLOOD BAGS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. VIALS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. OTHERS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
CHAPTER 5 GLOBAL BLOOD COLLECTION MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. DIAGNOSTICS
5.2.1. Market size and forecast
5.2.2. Infectious Diseases
5.2.3. Non-infectious Diseases
5.3. TREATMENT
5.3.1. Market size and forecast
CHAPTER 6 GLOBAL BLOOD COLLECTION MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS AND DIAGNOSTIC CENTERS
6.2.1. Market size and forecast
6.3. BLOOD BANKS
6.3.1. Market size and forecast
6.4. OTHER END USERS
6.4.1. Market size and forecast
CHAPTER 7 BLOOD COLLECTION MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. MEDTRONIC
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. BECTON DICKINSON AND COMPANY
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. TERUMO CORPORATION
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. NIPRO MEDICAL CORPORATION
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. QIAGEN
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. F.L. MEDICAL SRL
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. GREINER HOLDING AG
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. HAEMONETICS CORPORATION
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. SARSTEDT AG & CO
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
